Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 327

recruiting
3 983
countries
28
conditions
2 109

4 499 trials match your criteria

Dermatitis atopic

Not recruiting

Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Hydrocortisone

Study on the Effectiveness and Safety of OCS-01 Eye Drops with Dexamethasone for Patients with Diabetic Macular Edema

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Study on the Effectiveness and Safety of Afimetoran for Patients with Active Lupus

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Study on Sacituzumab Govitecan for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer Resistant to Hormone and CDK4/6 Inhibitors

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Osteochondrodysplasia+1

Not recruiting

Study on the Safety and Effects of SAR442501 for Children with Achondroplasia

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years

Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End Stage Kidney Disease on Hemodialysis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Breast cancer

Not recruiting

Study on the Effects of Samuraciclib and Elacestrant for Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Samuraciclib

Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End-Stage Kidney Disease on Hemodialysis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Follicular lymphoma+2

Not recruiting

Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Study of GS-5718 for Patients with Cutaneous Lupus Erythematosus (CLE)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.